3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
6
Lymphoid
3
Plasma cell
2
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Conditions
Multiple Myeloma
5
Lymphoma
3
Leukemia
2
Hematologic Neoplasms
2
Interventions
fludarabine phosphate
19
fludarabine
18
Cyclophosphamide
16
Tacrolimus
12
Whole-Body Irradiation
11
Melphalan
11
Mycophenolic Acid
10
Bortezomib
9
Busulfan
8
trametinib
7
Dexamethasone
7
thymoglobulin
6
Stem Cell Transplantation
6
Lenalidomide
6
Cyclosporine
6
Sirolimus
5
Nivolumab
5
Methotrexate
5
dabrafenib
4
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Granulocyte Colony-Stimulating Factor
4
Antilymphocyte Serum
4
Alemtuzumab
4
daratumumab
3
aldesleukin
3
Thiotepa
3
Specimen Handling
3
Ipilimumab
3
Interleukin-2
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
Palliative Care
×
Plasma cell
×
Clear all
NCT05646576
2026-04-21
PEACE
Massachusetts General Hospital
Phase NA
Recruiting
90 enrolled
NCT05190653
2024-07-31
PALS_CT
Alberta Health Services, Calgary
Phase NA
Recruiting
152 enrolled